Literature DB >> 15618074

Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques.

Karen M Modesto1, Angela Dispenzieri, Sanderson A Cauduro, Martha Lacy, Bijoy K Khandheria, Patricia A Pellikka, Marek Belohlavek, James B Seward, Robert Kyle, A Jamil Tajik, Morie Gertz, Theodore P Abraham.   

Abstract

AIMS: To assess left atrial (LA) function and determine the prevalence of LA dysfunction in AL amyloidosis (AL) using conventional and strain echocardiography. METHODS AND
RESULTS: LA ejection fraction, LA filling fraction, LA ejection force, peak LA systolic strain rate (LAsSR), and LA systolic strain (LA epsilon) were determined in 95 AL patients (70 with and 25 without echocardiographic evidence of cardiac involvement, abbreviated CAL and NCAL, respectively), 30 age-matched controls (CON), and 20 patients with diastolic dysfunction and LA dilatation (DD). Peak LAsSR >2 standard deviations below mean CON value was used as the cut-off for normal LA function. LA ejection fraction was lower in CAL when compared with CON (40.4+/-13.6 vs. 67.0+/-6%, P=0.01). Left atrial septal strain rate and strain were lower in CAL (0.8+/-0.5 s(-1) and 5.5+/-4%, respectively) compared with CON (1.8+/-0.8 s(-1) and 14+/-4%, respectively, P=<0.0001), NCAL (1.6+/-0.8 s(-1) and 13+/-7%, respectively, P<0.0001) and DD (1.3+/-0.4 s(-1) and 10+/-2%, respectively, P<0.0001). Based on peak LA systolic strain rate criteria, the cut-off values for normal LA function were -1.1 s(-1) and -1.05 s(-1) for lateral and septal walls. Using these criteria, LA dysfunction was identified in 32% (lateral LA criteria) and 60% (septal LA criteria) of CAL patients. Lateral and septal LAsSR were lower in CAL patients with vs. those without symptoms of heart failure. Inter- and intra-observer agreement was high for LA strain echocardiography.
CONCLUSION: LA function assessment using strain echocardiography is feasible with low intra- and inter-observer variability. LA dysfunction is observed in AL patients without other echocardiographic features of cardiac involvement and may contribute to cardiac symptoms in CAL.

Entities:  

Mesh:

Year:  2004        PMID: 15618074     DOI: 10.1093/eurheartj/ehi040

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

Review 1.  Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.

Authors:  David C Seldin; John L Berk; Flora Sam; Vaishali Sanchorawala
Journal:  Heart Fail Clin       Date:  2011-05-20       Impact factor: 3.179

Review 2.  Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 3.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

4.  How to image cardiac amyloidosis.

Authors:  Rodney H Falk; Candida C Quarta; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2014-05       Impact factor: 7.792

Review 5.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 6.  Left atrial function: evaluation by strain analysis.

Authors:  Gary C H Gan; Aaisha Ferkh; Anita Boyd; Liza Thomas
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

7.  Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.

Authors:  Satoru Yamamura; Yasuhiro Izumiya; Toshifumi Ishida; Yoshiro Onoue; Yuichi Kimura; Shinsuke Hanatani; Satoshi Araki; Koichiro Fujisue; Daisuke Sueta; Hisanori Kanazawa; Seiji Takashio; Hiroki Usuku; Koichi Sugamura; Kenji Sakamoto; Eiichiro Yamamoto; Megumi Yamamuro; Hisayo Yasuda; Sunao Kojima; Koichi Kaikita; Seiji Hokimoto; Hisao Ogawa; Kenichi Tsujita
Journal:  Heart Vessels       Date:  2016-11-23       Impact factor: 2.037

8.  Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.

Authors:  Raymond Y Kwong; Bobak Heydari; Siddique Abbasi; Kevin Steel; Mouaz Al-Mallah; Henry Wu; Rodney H Falk
Journal:  Am J Cardiol       Date:  2015-05-22       Impact factor: 2.778

9.  Left atrial booster-pump function as a predictive parameter for new-onset postoperative atrial fibrillation in patients with severe aortic stenosis.

Authors:  Junichi Imanishi; Hidekazu Tanaka; Takuma Sawa; Yoshiki Motoji; Tatsuya Miyoshi; Yasuhide Mochizuki; Yuko Fukuda; Kazuhiro Tatsumi; Kensuke Matsumoto; Yutaka Okita; Ken-ichi Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-08       Impact factor: 2.357

Review 10.  Natural history and therapy of AL cardiac amyloidosis.

Authors:  Martha Grogan; Angela Dispenzieri
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.